Retraction
Potential Use of Anti-Cancer Drugs for Treatment of Preeclampsia by Targeting the miRNA-IGF1R-PI3K-AKT Axis
Paper Information
Record ID:
56359
Author(s):
Publication Date:
August 22, 2022
Retraction Date:
October 04, 2023
(2.1 years years ago)
Subjects:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Hindawi
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
- Concerns/Issues About Data
- Concerns/Issues about Results and/or Conclusions
- Concerns/Issues about Referencing/Attributions
- Concerns/Issues with Peer Review
- Investigation by Journal/Publisher
- Investigation by Third Party
- Paper Mill
- Computer-Aided Content or Computer-Generated Content
- Unreliable Results and/or Conclusions
Nature of Retraction:
Retraction
Retraction Notice:
10.1155/2023/9764530Additional Notes:
See also: https://pubpeer.com/publications/7BFA317CFFF5762338FE85C24C2869
Citations (3)
3
Total Citations1
Post-Retraction(33.3%)
1
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
1
Within 1 year
0
After 2+ years
268
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
RNA-seq reveals differentially expressed lncRNAs and circRNAs and their associated functional network in HTR-8/Svneo cells under hypoxic conditions
Jiaqing Zhou, YueHua Sheng, Zhezhan Chen et al. (5 authors)
BMC Medical Genomics
Open Access
Published: Jun 2024
1 citation
1 citation
268 days after retraction
Retracted: Potential Use of Anti‐Cancer Drugs for Treatment of Preeclampsia by Targeting the miRNA‐IGF1R‐PI3K‐AKT Axis
Evidence-Based Complementary and Alternative Medicine
Evidence-based Complementary and Alternative Medicine
Open Access
Published: Jan 2023
276 days before retraction
Quick Stats
Total Citations:
4
Years Since Retraction:
2.1 years
Open Access:
Yes
Last Checked:
Jul 24, 2025